303 related articles for article (PubMed ID: 7622972)
1. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study.
Supiyaphun P; Tonsakulrungruang K; Chochaipanichnon L; Chongtateong A; Samart Y
J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.
Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P
J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571
[TBL] [Abstract][Full Text] [Related]
3. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation.
Supiyaphun P; Kerekhanjanarong V; Koranasophonepun J; Sastarasadhit V
J Med Assoc Thai; 2000 Jan; 83(1):61-8. PubMed ID: 10710871
[TBL] [Abstract][Full Text] [Related]
5. Bacteriology of chronic suppurative otitis media: ofloxacin susceptibility.
Yuen AP; Chau PY; Wei WI
J Otolaryngol; 1995 Jun; 24(3):206-8. PubMed ID: 7674449
[TBL] [Abstract][Full Text] [Related]
6. The development of antibiotic resistant organisms with the use of ototopical medications.
Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
[TBL] [Abstract][Full Text] [Related]
7. [Clinical success of treatment of chronic otitis media using topical and peroral administration of ofloxacin].
Kovacić M; Dzelalija B
Lijec Vjesn; 1999 Jun; 121(6):185-7. PubMed ID: 10494153
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
Klein JO
Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
10. Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study.
Yuen PW; Lau SK; Chau PY; Hui Y; Wong SF; Wong S; Wei WI
Am J Otol; 1994 Sep; 15(5):670-3. PubMed ID: 8572070
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.
Tong MC; Woo JK; van Hasselt CA
J Laryngol Otol; 1996 Apr; 110(4):309-14. PubMed ID: 8733449
[TBL] [Abstract][Full Text] [Related]
12. Microbiology of chronic suppurative otitis media in Singapore.
Loy AH; Tan AL; Lu PK
Singapore Med J; 2002 Jun; 43(6):296-9. PubMed ID: 12380726
[TBL] [Abstract][Full Text] [Related]
13. Topical ciprofloxacin versus topical gentamicin for chronic otitis media.
Nawasreh O; Fraihat A
East Mediterr Health J; 2001; 7(1-2):26-30. PubMed ID: 12596948
[TBL] [Abstract][Full Text] [Related]
14. The use of topical ofloxacin for otic diseases in infants and children. Summary and conclusions.
Klein JO; McCracken GH
Pediatr Infect Dis J; 2001 Jan; 20(1):123-5. PubMed ID: 11176592
[No Abstract] [Full Text] [Related]
15. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
Torum B; Block SL; Avila H; Montiel F; Oliva A; Quintanilla W; Duncanson F; Cantrell HF; Riefler J; Katz E; Lombardy E
Clin Ther; 2004 Jul; 26(7):1046-54. PubMed ID: 15336469
[TBL] [Abstract][Full Text] [Related]
16. Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea.
Jinnouchi O; Kuwahara T; Ishida S; Okano Y; Kasei Y; Kunitomo K; Takeda N
Auris Nasus Larynx; 2012 Aug; 39(4):374-7. PubMed ID: 21862264
[TBL] [Abstract][Full Text] [Related]
17. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.
Levy R; Shpitzer T; Shvero J; Pitlik SD
Laryngoscope; 1990 May; 100(5):548-51. PubMed ID: 2109817
[TBL] [Abstract][Full Text] [Related]
18. Role of glucocorticoids in ototopical antibiotic-steroid preparations in the treatment of chronic suppurative otitis media.
Indudharan R; Valuyeetham KA; Raju SS
Arch Med Res; 2005; 36(2):154-8. PubMed ID: 15847949
[TBL] [Abstract][Full Text] [Related]
19. Bacteriology and drug sensitivity of chronic suppurative otitis media at a central hospital in Zimbabwe.
Anifasi WB; Tumushime-Buturo CG
Cent Afr J Med; 1989 Sep; 35(9):481-3. PubMed ID: 2611874
[TBL] [Abstract][Full Text] [Related]
20. Topical ofloxacin for chronic suppurative otitis media and acute exacerbation of chronic otitis media: optimum duration of treatment.
Suzuki K; Nishimura T; Baba S; Yanagita N; Ishigami H
Otol Neurotol; 2003 May; 24(3):447-52. PubMed ID: 12806297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
